Literature DB >> 1636668

The maturation of morphine clearance and metabolism.

T I McRorie1, A M Lynn, M K Nespeca, K E Opheim, J T Slattery.   

Abstract

OBJECTIVE: To determine how early in childhood the clearance of morphine sulfate reaches that in adults.
DESIGN: Patient series.
SETTING: Children's Hospital and Medical Center, Seattle, Wash. PARTICIPANTS: Forty-nine children aged 1 day to 2.5 years with normal renal and hepatic function. All children were receiving a constant rate intravenous infusion of morphine for postoperative analgesia for greater than 24 hours.
INTERVENTIONS: Blood and urine samples were collected during infusion and immediately after discontinuation of the morphine infusion. MEASUREMENTS: Morphine concentrations were determined and clearance was calculated using the infusion data. Half-life and volume of distribution were calculated using the postinfusion data. The formation of metabolites was evaluated using the urine data. Morphine clearance increased with age, median clearances ranging from 5 mL/kg per minute in neonates aged 1 to 7 days to 21 mL/kg per minute in infants aged 6 months and older. This change in clearance correlated with age. The formation clearance of morphine glucuronide was correlated with age, whereas the formation clearance of morphine sulfate and the renal clearance of morphine were independent of age.
CONCLUSIONS: Morphine clearance reaches adult values by age 6 months to 2.5 years. In contrast to previous reports on the maturation of sulfate conjugation, it does not appear that morphine sulfate clearance is enhanced relative to glucuronidation in early infancy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1636668     DOI: 10.1001/archpedi.1992.02160200094036

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  35 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 2.  Common errors of drug administration in infants: causes and avoidance.

Authors:  B J Anderson; J F Ellis
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 3.  Strong opioids in pediatric palliative medicine.

Authors:  Richard D W Hain; Angela Miser; Mary Devins; W Hamish B Wallace
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

4.  Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates.

Authors:  Jeroen W B Peters; Brian J Anderson; Sinno H P Simons; Donald R A Uges; Dick Tibboel
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Opioid-induced Respiratory Depression Is Only Partially Mediated by the preBötzinger Complex in Young and Adult Rabbits In Vivo.

Authors:  Astrid G Stucke; Justin R Miller; Ivana Prkic; Edward J Zuperku; Francis A Hopp; Eckehard A E Stuth
Journal:  Anesthesiology       Date:  2015-06       Impact factor: 7.892

Review 6.  Clinical pharmacokinetics of sedatives in neonates.

Authors:  E Jacqz-Aigrain; P Burtin
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

Review 7.  Preoperative and postoperative pain control.

Authors:  R Howard
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

Review 8.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 9.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism.

Authors:  Nancy J Bouwmeester; Wim C J Hop; Monique van Dijk; K J S Anand; John N van den Anker; Dick Tibboel
Journal:  Intensive Care Med       Date:  2003-07-25       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.